Toll-like receptor 2 (TLR2)-mediated NF-κB activation induces VC in atherosclerosis by activating p38 and ERK1/2 signaling and inhibiting osteoprotegerin (OPG) expression (Lee et al., 2019). The gene discussed is NFKB1; the disease is atherosclerosis.